stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Belite Bio Inc AdrBLTE
$129.0714.54%-21.96

Belite Bio Inc Adr (BLTE)

Belite Bio Inc Adr stock is traded at $129.07, with a volume of 529,922. It is down -14.54% in the last 24 hours and down -16.44% over the past month. Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.
Previous Close:
$151.02
Open:
$129.00
24h Volume:
529,922
Relative Volume:
2.52
Market Cap:
$5.24B
Revenue:
-
Net Income/Loss:
-$77.61M
P/E Ratio:
-
EPS:
-$2.30
Net Cash Flow:
-
1W Performance:
-21.47%
1M Performance:
-16.44%
6M Performance:
-9.97%
1Y Performance:
+18.21%
1-Day Range:
$120.00$135.00
1-Week Range:
$120.00$166.50
52-Week Range:
$105.88$200.00

Belite Bio Inc Adr Stock (BLTE) Company Profile

Name
Belite Bio Inc Adr
Phone
-
Address
USA
Employee
41
X
-
Next Earnings Date
-
Latest SEC Filings
SEC
BLTE's Discussions on X
X

 

Market Cap

 

Revenue

 

Net Income

 

Cash Flow

 

EPS

 

Belite Bio Inc Adr Stock (BLTE) Financials Data

Similar to BLTE